ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1242
0,38%
Bitcoin
69.498,46
-2,73%
Brent Oil
82,425
-1,32%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cumberland Pharmaceutical Inc (CPIX)

  7. Cumberland Pharmaceutical Inc (CPIX) Notícias

CPIX

Cumberland Pharmaceutical (CPIX)

Cumberland Pharmaceutical Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CPIX
DataHoraFonteTítuloCódigoCompanhia
10/05/202417:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202418:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202417:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
30/04/202417:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
02/04/202417:05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202418:05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/02/202418:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/02/202419:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202319:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
27/12/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CPIXCumberland Pharmaceutical Inc
15/12/202318:14Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:CPIXCumberland Pharmaceutical Inc
14/12/202319:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202319:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202318:05PR Newswire (US)Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
31/10/202317:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
10/10/202317:05PR Newswire (US)NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGENASDAQ:CPIXCumberland Pharmaceutical Inc
27/09/202311:55Dow Jones NewsCorrection to SEC Fines ArticleNASDAQ:CPIXCumberland Pharmaceutical Inc
27/09/202311:43Dow Jones NewsSEC Fines 5 Public Companies, Insiders Over Reporting FailuresNASDAQ:CPIXCumberland Pharmaceutical Inc
08/08/202317:05PR Newswire (US)Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023NASDAQ:CPIXCumberland Pharmaceutical Inc
01/08/202317:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
26/06/202310:00PR Newswire (US)NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTSNASDAQ:CPIXCumberland Pharmaceutical Inc
22/06/202307:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CPIXCumberland Pharmaceutical Inc
23/05/202310:00PR Newswire (US)CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSISNASDAQ:CPIXCumberland Pharmaceutical Inc
16/05/202318:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CPIXCumberland Pharmaceutical Inc
15/05/202310:00PR Newswire (US)CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/05/202317:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
02/05/202317:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
27/03/202318:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPIXCumberland Pharmaceutical Inc
15/03/202308:41Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CPIXCumberland Pharmaceutical Inc
13/03/202318:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CPIXCumberland Pharmaceutical Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CPIX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
PRIO3
PETRORIO ON
BOV
HAGA3
HAGA ON
BOV
COGN3
COGNA ON
BOV
SGPS3
SPRINGS ON
BOV
INBR32
Inter &
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
LUPA3
LUPATECH ON
BOV
AZEV4
AZEVEDO PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
GFSA3
GAFISA ON
BOV
CASH3
Meliuz S.A ON
BOV
AMAR3
LOJAS MARISA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
JHSF3
JHSF PART ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados